TAM-derived exosomal miR-589-3p accelerates ovarian cancer progression through BCL2L13

Jianqing Wang1, Yan Zhu1, Yang He1

  • 1Department of Gynecology and Obstetrics, Yancheng First People's Hospital, Yancheng Clinical College of Xuzhou Medical University, Yancheng, Jiangsu, 224002, China.

Journal of Ovarian Research
|February 22, 2025
PubMed
Abstract

Insights

Tumor-associated macrophages (TAM) release exosomes containing miR-589-3p, which promote ovarian cancer (OC) progression by targeting BCL2L13. Inhibiting this exosomal microRNA offers a potential therapeutic strategy for OC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Tumor-associated macrophages (TAM) are key in the tumor microenvironment (TME).
  • Exosomes mediate intercellular communication between tumor cells and the TME.
  • MicroRNAs (miRNAs) play a crucial role in ovarian cancer (OC) development.

Purpose of the Study:

  • To investigate the role of TAM-derived exosomal miR-589-3p in OC progression.
  • To elucidate the molecular mechanisms underlying miR-589-3p's function in OC.

Main Methods:

  • Polarization of peripheral blood mononuclear cells (PBMCs) into M2-type macrophages.
  • Isolation and characterization of exosomes using TEM and NTA.
  • qRT-PCR to quantify gene expression.
  • Bioinformatic prediction and experimental validation (dual luciferase, RIP assays) of miR-589-3p targets.
  • Assessment of OC cell proliferation and apoptosis using CCK-8 and flow cytometry.

Main Results:

  • TAM-derived exosomes promote OC cell proliferation and inhibit apoptosis.
  • miR-589-3p expression is upregulated in OC cells co-cultured with TAM-derived exosomes.
  • miR-589-3p directly targets and binds to BCL2L13.
  • Inhibiting miR-589-3p in TAM-derived exosomes attenuates OC progression.

Conclusions:

  • TAM-derived exosomal miR-589-3p promotes OC progression by targeting BCL2L13.
  • This finding presents a novel therapeutic target for ovarian cancer.